
Alnylam Pharmaceuticals Inc (ALNY)
NASDAQ
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | -166.48M | -225.46M | 133.95M | 104.16M | -81.52M | 42.64M | 86.35M | -8.31M |
Cash from Investing Activities | -76.22M | -84.93M | -95.69M | -336.35M | -67.62M | -33.68M | -63.93M | -116.84M |
Cash from Financing Activities | 46.37M | 99.77M | 132.9M | 172.13M | 28.91M | 160.41M | 263.16M | 294.16M |
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | -382.79M | -562.62M | -278.43M | -614.96M | -641.69M | -541.27M | 104.16M | -8.31M |
Cash from Investing Activities | -290.36M | 272.95M | -417.68M | -435.52M | -273.3M | 169.35M | -336.35M | -116.84M |
Cash from Financing Activities | 1.12B | 65.47M | 823.18M | 994.98M | 1.25B | 425.75M | 172.13M | 294.16M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.